Evaluation of Safety and Immunogenicity of Combined Immunization of PPV23 and IIV4

Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2020
Subjects will be recruited and divided into 3 groups: 1. Experimental Group (408 subjects): combined immunization of PPV23 and IIV4; 2. Control Group A (408 subjects): IIV4 only; 3. Control Group B (408 subjects): PPV23 only; All blood samples will be collected before and one month after vaccinatioin. The immunogenicity and safety of both experimental and control groups will be compared and the data be analyzed.
Epistemonikos ID: d2acadbfb0f87827893aa60591e238e3fa007812
First added on: May 07, 2024